Go Pro
→ Stranded On The Flood Plains of History (From Porter & Company) (Ad)tc pixel Free MDNA Stock Alerts

Medicenna Therapeutics (MDNA) Competitors

Medicenna Therapeutics logo
C$0.40 0.00 (0.00%)
As of 06/30/2026 03:49 PM Eastern
Compare

MDNA vs. APM, GXE, CGC, WMD, and SGW

Should you buy Medicenna Therapeutics stock or one of its competitors? MarketBeat compares Medicenna Therapeutics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Medicenna Therapeutics include Andean Precious Metals (APM), Gear Energy (GXE), Canadian Gold (CGC), WeedMD (WMD), and Shoal Games (SGW). These companies are all part of the "pharmaceutical products" industry.

How does Medicenna Therapeutics compare to Andean Precious Metals?

Andean Precious Metals (CVE:APM) and Medicenna Therapeutics (TSE:MDNA) are both small-cap pharmaceutical products companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, media sentiment, analyst recommendations, earnings, valuation and risk.

Andean Precious Metals has a net margin of 16.17% compared to Medicenna Therapeutics' net margin of -533,640.00%. Andean Precious Metals' return on equity of 20.32% beat Medicenna Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Andean Precious Metals16.17% 20.32% 4.13%
Medicenna Therapeutics -533,640.00%-219.30%-32.80%

In the previous week, Medicenna Therapeutics had 2 more articles in the media than Andean Precious Metals. MarketBeat recorded 2 mentions for Medicenna Therapeutics and 0 mentions for Andean Precious Metals. Andean Precious Metals' average media sentiment score of 0.00 beat Medicenna Therapeutics' score of -0.31 indicating that Andean Precious Metals is being referred to more favorably in the media.

Company Overall Sentiment
Andean Precious Metals Neutral
Medicenna Therapeutics Neutral

Andean Precious Metals has higher revenue and earnings than Medicenna Therapeutics. Medicenna Therapeutics is trading at a lower price-to-earnings ratio than Andean Precious Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Andean Precious MetalsC$154.78M0.88C$37.41MC$0.512.55
Medicenna TherapeuticsN/AN/A-C$25.98M-C$0.15N/A

13.2% of Andean Precious Metals shares are held by institutional investors. Comparatively, 0.4% of Medicenna Therapeutics shares are held by institutional investors. 69.4% of Andean Precious Metals shares are held by insiders. Comparatively, 22.6% of Medicenna Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Andean Precious Metals has a beta of 1.22, suggesting that its stock price is 22% more volatile than the broader market. Comparatively, Medicenna Therapeutics has a beta of 2.891195, suggesting that its stock price is 189% more volatile than the broader market.

Summary

Andean Precious Metals beats Medicenna Therapeutics on 10 of the 12 factors compared between the two stocks.

How does Medicenna Therapeutics compare to Gear Energy?

Gear Energy (TSE:GXE) and Medicenna Therapeutics (TSE:MDNA) are both small-cap pharmaceutical products companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, media sentiment, profitability and valuation.

Gear Energy has a net margin of 5.77% compared to Medicenna Therapeutics' net margin of -533,640.00%. Gear Energy's return on equity of 3.52% beat Medicenna Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Gear Energy5.77% 3.52% 4.84%
Medicenna Therapeutics -533,640.00%-219.30%-32.80%

In the previous week, Medicenna Therapeutics had 2 more articles in the media than Gear Energy. MarketBeat recorded 2 mentions for Medicenna Therapeutics and 0 mentions for Gear Energy. Gear Energy's average media sentiment score of 0.00 beat Medicenna Therapeutics' score of -0.31 indicating that Gear Energy is being referred to more favorably in the media.

Company Overall Sentiment
Gear Energy Neutral
Medicenna Therapeutics Neutral

Gear Energy has a beta of 3.52, suggesting that its share price is 252% more volatile than the broader market. Comparatively, Medicenna Therapeutics has a beta of 2.891195, suggesting that its share price is 189% more volatile than the broader market.

2.4% of Gear Energy shares are held by institutional investors. Comparatively, 0.4% of Medicenna Therapeutics shares are held by institutional investors. 7.6% of Gear Energy shares are held by company insiders. Comparatively, 22.6% of Medicenna Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Gear Energy has higher revenue and earnings than Medicenna Therapeutics. Medicenna Therapeutics is trading at a lower price-to-earnings ratio than Gear Energy, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Gear EnergyC$134.93M0.00C$13.02MC$0.05N/A
Medicenna TherapeuticsN/AN/A-C$25.98M-C$0.15N/A

Summary

Gear Energy beats Medicenna Therapeutics on 10 of the 12 factors compared between the two stocks.

How does Medicenna Therapeutics compare to Canadian Gold?

Canadian Gold (CVE:CGC) and Medicenna Therapeutics (TSE:MDNA) are both small-cap pharmaceutical products companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

0.3% of Canadian Gold shares are owned by institutional investors. Comparatively, 0.4% of Medicenna Therapeutics shares are owned by institutional investors. 43.3% of Canadian Gold shares are owned by insiders. Comparatively, 22.6% of Medicenna Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Canadian Gold has a net margin of 0.00% compared to Medicenna Therapeutics' net margin of -533,640.00%. Canadian Gold's return on equity of -92.98% beat Medicenna Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Canadian GoldN/A -92.98% -48.06%
Medicenna Therapeutics -533,640.00%-219.30%-32.80%

In the previous week, Medicenna Therapeutics had 2 more articles in the media than Canadian Gold. MarketBeat recorded 2 mentions for Medicenna Therapeutics and 0 mentions for Canadian Gold. Canadian Gold's average media sentiment score of 0.00 beat Medicenna Therapeutics' score of -0.31 indicating that Canadian Gold is being referred to more favorably in the media.

Company Overall Sentiment
Canadian Gold Neutral
Medicenna Therapeutics Neutral

Canadian Gold has a beta of -1.586234, indicating that its stock price is 259% less volatile than the broader market. Comparatively, Medicenna Therapeutics has a beta of 2.891195, indicating that its stock price is 189% more volatile than the broader market.

Canadian Gold is trading at a lower price-to-earnings ratio than Medicenna Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Canadian GoldN/AN/A-C$3.62M-C$0.02N/A
Medicenna TherapeuticsN/AN/A-C$25.98M-C$0.15N/A

Summary

Canadian Gold beats Medicenna Therapeutics on 6 of the 11 factors compared between the two stocks.

How does Medicenna Therapeutics compare to WeedMD?

Medicenna Therapeutics (TSE:MDNA) and WeedMD (CVE:WMD) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability, media sentiment and risk.

0.4% of Medicenna Therapeutics shares are owned by institutional investors. 22.6% of Medicenna Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Medicenna Therapeutics has higher earnings, but lower revenue than WeedMD. Medicenna Therapeutics is trading at a lower price-to-earnings ratio than WeedMD, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medicenna TherapeuticsN/AN/A-C$25.98M-C$0.15N/A
WeedMDC$27.53M2.46-C$102.60M-C$0.42N/A

In the previous week, Medicenna Therapeutics had 2 more articles in the media than WeedMD. MarketBeat recorded 2 mentions for Medicenna Therapeutics and 0 mentions for WeedMD. WeedMD's average media sentiment score of 0.00 beat Medicenna Therapeutics' score of -0.31 indicating that WeedMD is being referred to more favorably in the news media.

Company Overall Sentiment
Medicenna Therapeutics Neutral
WeedMD Neutral

WeedMD has a net margin of 0.00% compared to Medicenna Therapeutics' net margin of -533,640.00%. WeedMD's return on equity of 0.00% beat Medicenna Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Medicenna Therapeutics-533,640.00% -219.30% -32.80%
WeedMD N/A N/A N/A

Summary

WeedMD beats Medicenna Therapeutics on 6 of the 11 factors compared between the two stocks.

How does Medicenna Therapeutics compare to Shoal Games?

Medicenna Therapeutics (TSE:MDNA) and Shoal Games (CVE:SGW) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.

Shoal Games has a net margin of 0.00% compared to Medicenna Therapeutics' net margin of -533,640.00%. Shoal Games' return on equity of 0.00% beat Medicenna Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Medicenna Therapeutics-533,640.00% -219.30% -32.80%
Shoal Games N/A N/A N/A

Shoal Games has higher revenue and earnings than Medicenna Therapeutics. Shoal Games is trading at a lower price-to-earnings ratio than Medicenna Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medicenna TherapeuticsN/AN/A-C$25.98M-C$0.15N/A
Shoal GamesC$106.98K612.86-C$5.25M-C$0.04N/A

0.4% of Medicenna Therapeutics shares are held by institutional investors. 22.6% of Medicenna Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Medicenna Therapeutics had 2 more articles in the media than Shoal Games. MarketBeat recorded 2 mentions for Medicenna Therapeutics and 0 mentions for Shoal Games. Shoal Games' average media sentiment score of 0.00 beat Medicenna Therapeutics' score of -0.31 indicating that Shoal Games is being referred to more favorably in the news media.

Company Overall Sentiment
Medicenna Therapeutics Neutral
Shoal Games Neutral

Summary

Shoal Games beats Medicenna Therapeutics on 7 of the 11 factors compared between the two stocks.

Get Medicenna Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDNA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MDNA vs. The Competition

Export
MetricMedicenna TherapeuticsBiotechnology IndustryMedical SectorTSE Exchange
Market CapC$32.95MC$502.14MC$6.80BC$12.17B
Dividend YieldN/A3.87%2.66%6.18%
P/E Ratio-2.633.1727.4835.73
Price / SalesN/A6,611.67541.4710.12
Price / Cash1.1513.1348.5382.29
Price / Book13.2888.7710.974.47
Net Income-C$25.98M-C$96.07MC$3.57BC$299.09M
7 Day Performance-3.66%1.06%2.80%1.33%
1 Month Performance-8.14%1.01%1.93%-2.16%
1 Year Performance-53.53%75.05%36.49%37.26%

Medicenna Therapeutics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MDNA
Medicenna Therapeutics
N/AC$0.40
flat		N/A-53.5%C$32.95MN/AN/A20
APM
Andean Precious Metals
N/AC$1.29
+7.5%		N/A+0.0%C$135.47MC$154.78M2.5530
GXE
Gear Energy
N/AN/AN/AN/AC$126.52MC$134.93M10.391,310
CGC
Canadian Gold
N/AC$0.60
-6.3%		N/A+110.5%C$126.35MN/AN/A3,150
WMD
WeedMD
N/AC$0.28
-1.8%		N/A+0.0%C$67.82MC$27.53MN/A628

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:MDNA) was last updated on 7/1/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
DOJ Admits It In Court—Your Cash Can Be Seized Without Warning
The Department of Justice recently argued in court that cash may not be legally your property - raising concer...
Priority Gold | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel